Understanding the etiology of left ventricular hypertrophy is increasingly important due to the increasing number of targeted therapies coming online. This discussion provides a high-level approach to differentiating important causes of increased wall thickness.

In this interview, Timothy C. Wong, MD, MS, FACC and Sidney C. Smith Jr., MD, MACC discuss pitfalls in the diagnosis of HCM.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Incorporating spiritual evaluation into medical science is worth consideration. The presence of edifying emotions can potentially yield positive effects on hypertension treatment outcomes.

In this interview, Maria Emília Figueiredo Teixeira, MD, PhD and Sidney C. Smith Jr., MD, MACC discuss the primary findings uncovered by the Feel Trial.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

If there were a pill that could lower blood pressure, lower LDL cholesterol, improve erectile function and lower cardiovascular risk, would you take it? Good, because we already have it, and it comes pre-packaged in plant-based foods.

In this interview, Robert Ostfeld MD, MSc, FACC and Alison L. Bailey, MD FACC explore the vital link between nutrition and cardiovascular health.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Hypertrophic cardiomyopathy (HOCM) often goes unnoticed, yet as awareness grows, patients may find themselves more symptomatic than expected. How do doctors and patients navigate the array of management options, from medications to minimally invasive procedures or open-heart surgery? Discover what options offer the best chance for patients to feel their best, or even achieve a sense of normalcy, with minimal risk and hassle.

In this interview, Srihari S. Naidu, MD, FACC and Cindy L. Grines, MD, FACC, discuss HOCM: Selecting the Right Meds and Procedures.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Hypertrophic cardiomyopathy (HOCM) often goes unnoticed, yet as awareness grows, patients may find themselves more symptomatic than expected. How do doctors and patients navigate the array of management options, from medications to minimally invasive procedures or open-heart surgery? Discover what options offer the best chance for patients to feel their best, or even achieve a sense of normalcy, with minimal risk and hassle.

In this interview, Srihari S. Naidu, MD, FACC and Cindy L. Grines, MD, FACC, discuss HOCM: Selecting the Right Meds and Procedures.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Premature ventricular contractions (PVCs), commonly experienced as palpitations from occasional skipped heartbeats, are typically benign but can escalate to severe symptoms or heart failure in individuals with a high PVC burden. Understanding the most effective diagnostic tests for quantifying PVCs is crucial for guiding appropriate management strategies.

In this interview, Jim Cheung MD, FACC and Anthony N. DeMaria MD, MACC discuss PVC burden and its temporal variability.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Individuals from lower socioeconomic status (SES) backgrounds face heightened risks of morbidity and mortality, particularly in the context of health conditions such as cardiovascular disease. Despite this increased vulnerability, they often face barriers to accessing crucial secondary prevention programs, such as cardiac rehabilitation. How can we bridge this gap and ensure that these vulnerable patients receive the support they urgently need?

In this interview, Diann Gaalema, PhD and Anthony N. DeMaria, MD, MACC discuss financial incentives to improving cardiac rehab participation.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

In this interview, Stephen Greene, MD, FACC and Sidney C. Smith Jr., MD, MACC discuss inpatient initiation of HF GDMT.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Why should we assess plaque burden beyond luminal narrowing for cardiac prevention?

In this interview, Andrew Choi, MD, FACC and Clyde W. Yancy, MD, MSc, MACC discuss insights from data and studies involving plaque burden, morphology and flow.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Why should we assess plaque burden beyond luminal narrowing for cardiac prevention?

In this interview, Andrew Choi, MD, FACC and Clyde W. Yancy, MD, MSc, MACC discuss insights from data and studies involving plaque burden, morphology and flow.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL